Hennepin Health has made several changes to the drug formulary. These changes apply to Hennepin Health-PMAP, Hennepin Health-MNCare and Hennepin Health-SNBC members. Members who are directly impacted will receive notification of the changes. The updated full drug formulary is available on Hennepin Health's website. A printed copy can be obtained by calling Provider Services at 612-596-1036 (select option #2). Effective Aug. 1, 2024, these medications were added and utilization management (UM) requirements are listed if applicable: Alrex, QL = 5ml/30 days Bepreve, QL = 5ml/30 days Genotropin cartridge Genotropin syringe Mesalamine (Generic of Canasa), QL = 1 supp/day Olopatadine OTC (0.10%; 0.20%) Omega-3 acid ethyl esters (Generic of Lovaza) Testim Effective Aug. 1, 2024, these medications were removed: Alocril Beconase AQ Benzaclin (Topical) Benzaclin Gel Pump Bystolic Canasa Claravis Cap Clindagel Clindamycin/Benzoyl Peroxide (Acanya) with pump Colestgid Granules Coreg CR Corzide Dapagliflozin Delzicol Detrol LA Duexis Dutoprol Elestat Emadine Fesoterodine Fortesta Gelnique Kadian Lastacaft Levatol Lidoderm Memantine tablet dose pack (AG) Mesalamine (Generic of Lialda) Natesto Olopatadine (nasal) Pantanse Razadyne ER Razadyne tablet Vimovo Xipere